NASDAQ News. . . .
Biopure (Cambridge, Massachusetts) reported that NASDAQ has approved the company's application to transfer the listing of its common stock from the NASDAQ global market to the NASDAQ capital market. Biopure expects trading of its stock on the NASDAQ under its existing symbol, BPUR. Biopure Corporation develops, manufactures and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body's tissues.
Tripos (St. Louis) said it received a letter from the NASDAQ listing qualifications department advising them that for the year ended Dec. 31, 2006, Tripos did not comply with the minimum $10 million stockholders' equity requirement for continued inclusion on the NASDAQ Global Market under marketplace rule 4450(a)(3).
Tripos was given until May 3, 2007, to provide NASDAQ with a specific plan to achieve and sustain compliance with all NASDAQ Global Market listing requirements.
IsoRay now listed on Amex
The American Stock Exchange has listed the common stock of IsoRay (Richland, Washington) under the ticker symbol ISR.
"IsoRay does important work in the field of cancer therapy, and the American Stock Exchange is pleased to list their shares," said John McGonegal, senior VP of Amex's Equities Group. "We expect IsoRay will find itself in good company among the increasing number of innovative medical technology companies that have chosen to list at the Amex."
IsoRay is a medical isotope company focusing on brachytherapy solutions for prostate cancer and other malignant tissue cancers through use of its Cesium-131 radioisotope. IsoRay, through its subsidiary, IsoRay Medical, produces and sells the Cesium-131 brachytherapy seed currently used to treat prostate cancer.
Hill-Rom to open Innovation Center
Hillenbrand Industries (Batesville, Indiana) reported its Hill-Rom subsidiary has selected Batesville as home to its new globally-focused Innovation Center. The center will house Hill-Rom teams focused on research & development and new product ideation. Along with the opening of the center, Hill-Rom anticipates adding as many as 80 new jobs to be Indiana-based. The new positions will be added primarily in the engineering and marketing areas.
"Hill-Rom is one of the most recognized and revered names in health care. Yet we must constantly innovate to maintain this reputation," said Peter Soderberg, president/CEO of Hill-Rom and Hillenbrand Industries. "We have previously announced a significant increase in our corporate spending on R&D to insure we bring to market products and services that meet unmet needs and make a difference in health care. . .for both patients and their caregivers. We considered several sites for this expansion project, but in the final analysis, we recognized the strength of building right here where our headquarters is located and our heritage is strong. We see Batesville and the state of Indiana as good partners for our future and that made our choice easy."
To encourage expansion in Indiana, the Indiana Economic Development Corporation (IEDC) has announced Hill-Rom as the recipient of up to $2 million in tax credits over a period of 10 years and $173,000 in training grants. In exchange for these grants, Hill-Rom has agreed to meet certain employment measures including the creation of the new jobs and maintaining a specified percentage of its employment base in Indiana. The City of Batesville also will provide the company with property tax abatement worth $74,049.
Medical Simulation opens SimSuite Center
Medical Simulation Corporation (MSC; Denver) reported the opening of the Houston Regional SimSuite Education Center. The SimSuite is easily accessible to the Texas Medical Center and broader Houston Metroplex.
MSC is a full-service simulation-based education company dedicated to developing competent and confident healthcare professionals to provide high-quality patient care. Because real-life clinical scenarios are simulated, no patients are at risk while healthcare professionals continue to advance their technical and cognitive skills. The opportunity to train in a risk-free environment allows for lessons to be learned without consequence to a patient.
The MSC clinical curriculum focuses on courses for the hospital-based nurse as well as cardiology, interventional cardiology, interventional radiology, vascular surgery, and emergency room teams. Course participants may include physicians, physicians-in-training, nurses, technologists, medical device representatives, and pharmaceutical representatives.